Tsai LF

References (1)

Title : LEGACY: Phase 2a Trial to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamic Effects of the Anti-EL (Endothelial Lipase) Antibody MEDI5884 in Patients With Stable Coronary Artery Disease - Ruff_2021_Arterioscler.Thromb.Vasc.Biol__ATVBAHA120315757
Author(s) : Ruff CT , Koren MJ , Grimsby J , Rosenbaum AI , Tu X , Karathanasis SK , Falloon J , Hsia J , Guan Y , Conway J , Tsai LF , Hummer BT , Hirshberg B , Kuder J , Murphy SA , George RT , Sabatine MS
Ref : Arterioscler Thromb Vasc Biol , :ATVBAHA120315757 , 2021
Abstract :
PubMedSearch : Ruff_2021_Arterioscler.Thromb.Vasc.Biol__ATVBAHA120315757
PubMedID: 34706556